Clinical trial
Chemotherapy Related Anemia
NCT00035607 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00035607 |
|---|---|
| Title | Chemotherapy Related Anemia |
| Official title | A Randomized, Open-label, Multicenter Study of Subcutaneous and Intravenous Administration of Darbepoetin Alfa (Novel Erythropoiesis Stimulating Protein, NESP) for the Treatment of Anemia in Subjects With Non-myeloid Malignancies Receiving Multicycle Chemotherapy |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Non-Myeloid Malignancies |
| Intervention type | Drug |
| Interventions | Darbepoetin alfa SC, Darbepoetin alfa IV |
| Enrollment | 120 |
| Start date | Dec 1, 2001 |
| Primary completion | Dec 1, 2002 |
| Completion | Apr 1, 2003 |
| First posted | May 6, 2002 |
| Last update posted | May 13, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: